Page 122 - 南京医科大学学报自然科学版
P. 122
第41卷第4期
·592 · 南 京 医 科 大 学 学 报 2021年4月
Crit Care Med,2006,34(1):15-21 J,2019,49(9):1173-1177
[5] 徐腾飞,刘志武,金凤玲. 2012—2015 年医院血流感染 [14] 李光辉,朱德妹,汪 复,等. 2012年中国CHINET血培
病原菌分布及耐药性变迁[J]. 中国感染控制杂志, 养临床分离菌的分布及耐药性[J]. 中国感染与化疗杂
2017,16(10):936-940 志,2014(6):474-481
[6] WEINSTEIN M P,TOWNS M L,QUARTEY S M,et al. [15] PAPADIMITRIOU ⁃ OLIVGERI I,GIORMEZIS N,PA⁃
The clinical significance of positive blood cultures in the PADIMITRIOU⁃OLIVGERIS M,et al. Number of positive
1990s:a prospective comprehensive evaluation of the mi⁃ blood cultures,biofilm formation,and adhesin genes in
crobiology,epidemiology,and outcome of bacteremia and differentiating true coagulase⁃negative staphylococci bac⁃
fungemia in adults[J]. Clin Infect Dis,1997,24(4):584- teremia from contamination[J]. Eur J Clin Microbiol In⁃
602 fect Dis,2016,35(1):57-66
[7] CAZAUBON Y,BOURGUIGNON L,GOUTELLE S,et al. [16] 徐亚青,邓 敏. 261例血培养阳性病例的临床诊断及
Are ciprofloxacin dosage regimens adequate for antimicro⁃ 特征[J]. 中国感染控制杂志,2013,12(6):431-434
bial efficacy and prevention of resistance? Pseudomonas [17] 胡仁静,严子禾,韩志君,等. 感染碳青霉烯耐药的肠杆
aeruginosa bloodstream infection in elderly patients as a 菌科细菌患者全因死亡的 Meta 分析[J]. 南京医科大
simulation case study[J]. Fundam Clin Pharmacol,2015, 学学报(自然科学版),2016,36(12):1567-1572
29(6):615-624 [18]SHIRLEY M. Ceftazidime⁃avibactam:a review in the treat⁃
[8] HONDA H,HIGUCHI N,SHINTANI K,et al. Inadequate ment of serious gram ⁃ negative bacterial infections[J].
empiric antimicrobial therapy and mortality in geriatric Drugs,2018,78(6):675-692
patients with bloodstream infection:a target for antimicro⁃ [19] SUN Y,CAI Y,LIU X,et al. The emergence of clinical re⁃
bial stewardship[J]. J Infect Chemother,2018,24(10): sistance to tigecycline[J]. Int J Antimicrob Agents,2013,
807-811 41(2):110-116
[9] 查翔远,宋有良,金正胜,等. 老年血流感染患者107例 [20] WANG Y,WANG J,WANG R,et al. Resistance to cef⁃
病原菌分布和药敏分析[J]. 中国感染与化疗杂志, tazidime ⁃ avibactam and underlying mechanisms[J]. J
2017,17(1):77-81 Glob Antimicrob Resist,2020,22:18-27
[10] 孙 艳,邢 虎,单 琼,等. 老年住院患者血培养细菌 [21] RAMIREZ M S,BONOMO R A,TOLMASKY M E. Car⁃
分布与耐药性分析[J]. 中华医院感染学杂志,2019,29 bapenemases:transforming acinetobacter baumannii into
(20):3087-3090,3105 a yet more dangerous menace[J]. Biomolecules,2020,10
[11] 张秀红,惠姣洁,董 亮,等. 无锡市某医院老年患者血 (5):720
培养病原菌分布及耐药性[J]. 中国感染控制杂志, [22] SAVOV E,TRIFONOVA A,KOVACHKA K,et al. Anti⁃
2019,18(1):1-5 microbial in vitro activities of ceftazidime⁃avibactam,me⁃
[12] 马李平,冯旰珠,杜兴冉. 肺炎克雷伯菌血流感染耐药 ropenem⁃vaborbactam and plazomicin against multidrug⁃
及死亡的危险因素分析[J]. 南京医科大学学报(自然 resistant Acinetobacter baumannii and Pseudomonas aeru⁃
科学版),2016,36(12):1466-1470 ginosa ⁃ a pilot Bulgarian study[J]. Infect Dis(Lond),
[13] HANGER H C,BLOOR M. Inpatient healthcare⁃associat⁃ 2019,51(11/12):870-873
ed bloodstream infections in older people[J]. Intern Med [收稿日期] 2020-08-01